Related Experiment Video
Updated: Aug 18, 2026

Deficient Pms2, ERCC1, Ku86, CcOI in Field Defects During Progression to Colon Cancer
Published on: July 29, 2010
Mechanisms for species differences in receptor-mediated carcinogenesis
1Laboratory of Molecular Carcinogenesis, National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, NC 27709, USA.
Abstract:
Species differences resulting from a number of mechanisms are common in receptor-mediated chemical carcinogenesis. In this review, examples of possible mechanisms underlying these differences are discussed, including ligand metabolism, receptor polymorphisms, receptor isoforms, receptor levels, and crosstalk between signal transduction pathways. In addition, a number of other mechanisms also are likely to be important. The developmental state of the animal will determine the expression of receptors in different tissues. The regulatory pathways for cell proliferation and cell death and cell cycle check point controls can vary among species and tissues. Adaptation or potentiation of responses during chronic exposures to chemicals can greatly influence species differences. The mechanisms of adaptive processes are poorly understood but probably highly important for chronic toxicities such as cancer. Finally, different species may have different stem cell populations that are the targets for neoplastic transformation, and this will influence receptor-mediated carcinogenic responses. The implications of species differences in receptor-mediated responses for risk assessment are discussed.
Insights
Species differences in chemical carcinogenesis are influenced by various factors, including how chemicals are processed and how cells respond. Understanding these variations is crucial for accurate risk assessment.
Area of Science:
- Toxicology
- Carcinogenesis
- Pharmacology
Background:
- Receptor-mediated chemical carcinogenesis exhibits significant species-specific variations.
- These differences complicate the extrapolation of toxicological data across species.
Purpose of the Study:
- To review and discuss the mechanisms underlying species differences in receptor-mediated chemical carcinogenesis.
- To highlight the implications of these differences for risk assessment.
Main Methods:
- Literature review of studies on receptor-mediated chemical carcinogenesis.
- Analysis of various mechanisms contributing to interspecies variability.
Main Results:
- Key mechanisms include ligand metabolism, receptor polymorphisms/isoforms/levels, and signal transduction pathway crosstalk.
- Developmental stage, tissue-specific receptor expression, and cell cycle regulation also play roles.
- Adaptive responses to chronic chemical exposure and differences in target stem cell populations contribute significantly.
Conclusions:
- Species differences in receptor-mediated carcinogenesis are multifactorial.
- A comprehensive understanding of these mechanisms is essential for accurate toxicological risk assessment.
More Related Videos
07:29Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment
Published on: April 22, 2019
04:12Chemical-Induced Skin Carcinogenesis Model Using Dimethylbenz[a]Anthracene and 12-O-Tetradecanoyl Phorbol-13-Acetate (DMBA-TPA)
Published on: December 19, 2019
Related Concept Videos
Mitogens and the Cell Cycle
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Mutagenicity and Carcinogenicity